Sage Therapeutics (SAGE)
(Real Time Quote from BATS)
$14.61 USD
+0.92 (6.72%)
Updated Apr 29, 2024 01:26 PM ET
3-Hold of 5 3
F Value B Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Sage Therapeutics, Inc. [SAGE]
Reports for Purchase
Showing records 61 - 80 ( 152 total )
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
SHORELINE 50mg Data Validates Benefit But Shows That More Isnt Always Better; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
More Of The Same (A Good Thing) - Updated SHORELINE Results
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
CORAL Trials Primary Endpoint Change Adds to Confusion; Reiterate Neutral, PT to $55
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Four Key Takeaways From Zuranolone Data Presentation at ECNP; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Biotechnology- Investor Day Takeaways, Read Throughs
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Incremental Pipeline Update on Quiet 2Q Call; Reiterate Neutral, Price Target Down to $80
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
SKYLARK Shifts But Won''t Slow Down Zuranolone Efforts
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Zuranolone Goes Down Waterfall in a Barrel; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Going Over The WATERFALL Results - We Still Think There''s A Path Forward
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Sage Casts a Spotlight on 718 and NMDA Program; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Spotlight on SAGE-718 and NMDA Platform (For Today)
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Sage-718 Is Latest Asset to Advance in Rich Pipeline on 1Q Call as We Await WATERFALL
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Final Countdown to WATERFALL - Continue to Like the Chances for Success
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
SAGE-324 Hits Primary Endpoint, But Sage Still Has More Work to Do; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D